E. Ike, MS - Doctoral Student H. Kim, MS - Graduate Student Espinal, MS - Research Endo, MD - Assistant Professor, M. Sasano, MS - Research Assistant, H.

189 WEDNESDAY SCIENTIFIC SESSIONS Final Program ------------------------------------------------------------------------ 235 V Symposium Recognizing and Managing Antiviral Resistance Wednesday, 9:15 a.m.–11:15 a.m. . . . . . . . . . . . . . . . . Room 120 UAN: 0391-9999-12-174-L04-P Conveners: Guy Boivin, MD - Professor of Microbiology Laval Univ., Quebec, Canada. Joseph Eron, Jr., MD - Professor of Medicine Univ. of North Carolina, Chapel Hill, NC. Speakers: 9:15 a.m. 1893 Management of HIV Resistance: New Perspectives Ian Frank, MD - Professor of Medicine Univ. of Pennsylvania, Philadelphia, PA. 9:45 a.m. 1894 CMV: When to Think About Resistance and When to Switch Therapy? Sunwen Chou, MD - Professor of Medicine Oregon Hlth. and Sci. Univ., Portland, OR. 10:15 a.m. 1895 Influenza: How Resistance Emerges and the Role of Combina- tion Therapy Maria Zambon, PhD - Director, Reference Microbiology Services Hlth. Protection Agency, London, United Kingdom. 10:45 a.m. 1896 How to Avoid Resistance When Treating Hepatitis B Lorne Tyrrell, MDPhD - Professor and Director of the Li Ka Shing Institute of Virology Univ. of Alberta, Edmonton, Canada. Objectives: Upon completion of this Symposium Session, the participant should be able to: Discuss the increasing problem of antiviral resistance; Identify risk factors for selecting for drug-resistant viruses; Discuss the consequences of drug-resistant infections; and Propose potential alternate therapeutic strategies. Intended Audience: enteral infectious diseases specialists, HIV specialists, virologists, clinical microbiologists, and epidemiologists. Level: IntermediateAdvanced ------------------------------------------------------------------------ 236 C2 Slide Session Acinetobacter: Challenges and Continued Emergence Wednesday, 9:15 a.m.–11:45 a.m. . . . . . . . . . . . . . . . . Room 132 UAN: 0391-9999-12-175-L04-P Moderators: Jordi Vila, MD, PhD - Head of the Department of Clinical Microbiology Hosp. Clinic, Barcelona, Spain. Robert A. Bonomo, MD - Professor Louis Stokes Cleveland Dept. of VA Med. Ctr., Cleveland, OH. Objectives: Upon the completion of this Slide Session, the participant should be able to: Discuss the world wide dissemination of A. baumannii; Identify information about predominant clones of A. baumannii; Discuss the present challenge for antimicrobial treatment of Acineto- bacter infections; and Discuss genetic elements related to resistance. Presentations: 9:15 a.m. C2-1897 Carbapenem-Resistant Acinetobacter baumannii: An Italian Nationwide Problem F. Luzzaro, Doctor - Doctor 1 , R. Migliavacca, PhD - Research 2 , S. Bracco, PhD student - Doctor 1 , A. Piazza, PhD Student - Doctor 2 , E. Nucleo, PhD - Research 2 , G. Rossolini, Professor - Professor 3 , L. Pagani, Professor of Clinical Microbiology - Professor 2 ; 1 A. Manzoni Hosp., Lecco, Italy, 2 Univ. of Pavia, Pavia, Italy, 3 Univ. of Siena, Siena, Italy. 9:30 a.m. C2-1898 Prevalence of Multidrug-Resistant Acinetobacter baumannii in Southwest Nigeria Tertiary Hospitals

W. E. Ike, MS - Doctoral Student

1 , B. A. Adeniyi, PhD - Professor 1 , O. O. Soge, PhD - Research Scientist 2 ; 1 Univ. of Ibadan, Ibadan, Nigeria, 2 Univ. of Washington, Seattle, WA. 9:45 a.m. C2-1899 Spread of Carbapenem-Resistant Acinetobacter baumannii Global Clone II in Asian Countries

D. H. Kim, MS - Graduate Student

1 , J. Y. Choi, MS - Research Assistant 1 , S. H. Kim, PhD - Project Manager 2 , D. R. Chung, MD - Professor 3,2 , J. H. Song, MD, PhD - Professor 3,2 , K. S. Ko, PhD - Professor 1,2 ; 1 Sungkyunkwan Univ. Sch. of Med., Suwon, Korea, Republic of, 2 APFID, Seoul, Korea, Re- public of, 3 Sungkyunkwan Univ. Sch. of Med., Seoul, Korea, Republic of. 10:00 a.m. C2-1900 Carbapenem Resistant in Acinetobacter baumannii: An Emerging Problem in Israel

P. Espinal, MS - Research

1 , M. Kasma, MS - Research 2 , Y. Lerman, MD - Research 2 , Y. Carmeli, PhD - Professor 2 , J. Vila, PhD - Professor 1 ; 1 Univ. of Barcelona, Hosp. Clinic, Barcelona, Spain, 2 Sourasky Med. Ctr., Tel Aviv, Israel. 190 SCIENTIFIC SESSIONS September 9-12 | 10:15 a.m. C2-1901 Molecular Identification and Characterization of Acineto- bacter Species Causing Bacteremia at a Japanese Tertiary Hospital

S. Endo, MD - Assistant Professor, M. Sasano, MS - Research Assistant, H.

Yano, MD - Lecture, H. Kanamori, MD - Assistant Professor, S. Inomata, MD - Assistant Professor, N. Ishibashi, MD - Assistant Professor, T. Aoyagi, MD - Assistant Professor, M. Hatta, MD - Assistant Professor, Y. Gu, MD - Assistant Professor, M. Yamada, MD - Assistant Professor, K. Tokuda, MD - Lecture, M. Kitagawa, MS - Assistant Professor, H. Kunishima, MD - Associate Professor, M. Kaku, MD - Professor; Tohoku Univ., Sendai, Japan. 10:30 a.m. C2-1902 First Outbreak of Multiresistant Acinetobacter baumannii Producing the Carbapenemase OXA 23 in Spain M. Merino, MSc - PhD Student, M. Poza, PhD - Researcher, M. J. Barba, CLT - Lab Assistant, S. Rumbo-Feal, MSc - PhD Student, A. Fernandez, MSc - PhD Student, M. Tomás, PhD - PhD Researcher, G. Bou, PhD - P rofessor; Univ. La Coruña, La Coruña, Spain. 10:45 a.m. C2-1903 Clinical and Microbiological Characteristics of Bloodstream Infection Caused by Acinetobacter baumannii Complex

H. Lee, MD, MS - Attending Doctor and Lecturer, S. Wu, Bachelor -